The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective

Objective: Immunotherapy for esophageal cancer is relatively novel but increasingly used. This study evaluated the early use of immunotherapy as an adjunct to neoadjuvant chemoradiotherapy before esophagectomy for locally advanced disease. Methods: Perioperative morbidity (composite of mortality, ho...

Full description

Bibliographic Details
Main Authors: Lye-Yeng Wong, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:JTCVS Open
Subjects:
chemoradiation
esophageal cancer
immunotherapy
neoadjuvant
survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273623000906

Internet

http://www.sciencedirect.com/science/article/pii/S2666273623000906

Similar Items